FROM this month more women
with postmenopausal osteoporosis
will be able to receive
reimbursement for Prolia
(denosumab) following an
expanded listing on the
Pharmaceutical Benefit Scheme.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 09 Aug 12 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Aug 12
THE Australian Competition and Consumer Commission (ACCC) has given the green light to the proposed merger of Arrow and Apotex (PD 10 May 2018), finding that the transaction “will not substantially lessen competition in any market”.
NEGOTIATIONS between the Pharmacy Guild of Australia and the Health Department have seen the release of amendments to the Pharmacy Location Rules (PD breaking news), with Health Minister Greg Hunt signing an Amending Determination this week to enact the new arrangements.